Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A clinical trial compared injectable cabotegravir given every eight weeks versus daily Truvada for HIV prevention.
Gilead Sciences provides the funds through its TRANScend initiative; Destination Tomorrow in the Bronx distributes them.
Black queer men of MOBI talk about it all—including OnlyFans, HIV and adult films—in this artful digital video series.
About 1.4 million adults in the United States identify as transgender. Many are at high risk of HIV.
A session at CROI 2020 focused on HIV prevalence and outcomes in these understudied populations.
Jevon Martin, CEO of Princess Janae Place, addresses the challenges facing trans people—including COVID-19.
Meet three individuals leading very different lives who are united by their shared experiences as older women living with HIV.
It is a day to draw attention to the continued violence endured by transgender people.
311 trans and gender-nonconforming people were murdered in the past year worldwide, according to a new report.
One of the largest FREE trans-specific conferences in the world.
The program’s home will be Callen-Lorde’s in-the-works site in downtown Brooklyn.
“Overall, the candidates seemed well informed around HIV/AIDS issues.”
This year’s U.S. Conference on AIDS honors those lost to HIV. How many of these faces do you recognize?
Expect “Ending the Epidemics realness,” disruptive innovation and Mother Elektra at #2019USCA.
Is generic PrEP in 2020 too good to be true?
#SHAAD debuts Tuesday, August 20. Here’s how you can be part of the Southern Solution.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.